Organon Will Use Gene Logic's Gene Express in Drug Discovery Effort

COLUMBIA, Md.--Gene Logic here has signed an agreement granting three years of access to its Gene Express Normal database of gene expression profiles to NV Organon, a pharmaceutical business unit of Akzo Nobel. As part of the collaboration, Gene Logic will also build a gene expression database for drug target discovery specific to certain of Organon's research programs. Gene Express includes a variety of human, rat, and mouse tissues, and a proprietary bioinformatics system to analyze and integrate the information.